A NOVEL RETINOID, 4-BENZOIC ACID (TAC-101), INDUCES APOPTOSIS OF HUMAN OVARIAN CARCINOMA CELLS AND SHOWS POTENTIAL AS A NEW ANTITUMOR AGENT FOR CLEAR CELL ADENOCARCINOMA
A NOVEL RETINOID, 4-BENZOIC ACID (TAC-101), INDUCES APOPTOSIS OF HUMAN OVARIAN CARCINOMA CELLS AND SHOWS POTENTIAL AS A NEW ANTITUMOR AGENT FOR CLEAR CELL ADENOCARCINOMA